MCCP
AMGN icon

Mission Creek Capital Partners’s Amgen AMGN Stock Holding History

Mission Creek Capital Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.8M Buy
12,744
+590
+5% +$210K 0.56% 49
2025
Q4 		$2.41M Buy
12,154
+346
+3% +$110K 0.49% 55
2025
Q3 		$1.98M Buy
11,808
+24
+0.2% +$6.96K 0.39% 64
2025
Q2 		$1.95M Sell
11,784
-102
-0.9% -$28.9K 0.43% 58
2025
Q1 		$2.21M Buy
11,886
+17
+0.1% +$5.02K 0.54% 47
2024
Q4 		$1.85M Buy
11,869
+2,324
+24% +$690K 0.4% 68
2024
Q3 		$3.08M Buy
9,545
+28
+0.3% +$9.16K 0.72% 38
2024
Q2 		$2.97M Buy
9,517
+107
+1% +$31.4K 0.75% 34
2024
Q1 		$2.68M Sell
9,410
-705
-7% -$206K 0.7% 40
2023
Q4 		$2.91M Buy
10,115
+221
+2% +$60.2K 0.75% 28
2023
Q3 		$2.66M Sell
9,894
-127
-1% -$31.7K 0.89% 28
2023
Q2 		$2.22M Buy
10,021
+715
+8% +$166K 0.72% 38
2023
Q1 		$2.25M Buy
9,306
+199
+2% +$48.8K 0.77% 35
2022
Q4 		$2.39M Sell
9,107
-210
-2% -$56.3K 0.85% 29
2022
Q3 		$2.1M Buy
9,317
+97
+1% +$23.5K 0.79% 38
2022
Q2 		$2.24M Sell
9,220
-108
-1% -$26.5K 0.75% 36
2022
Q1 		$2.26M Buy
9,328
+42
+0.5% +$9.65K 0.6% 49
2021
Q4 		$2.09M Buy
9,286
+31
+0.3% +$6.54K 0.42% 67
2021
Q3 		$1.97M Buy
9,255
+52
+0.6% +$12K 0.37% 66
2021
Q2 		$2.24M Buy
9,203
+137
+2% +$33.7K 0.36% 57
2021
Q1 		$2.26M Sell
9,066
-125
-1% -$29.8K 0.34% 48
2020
Q4 		$2.11M Buy
9,191
+595
+7% +$137K 0.65% 41
2020
Q3 		$2.19M Buy
8,596
+963
+13% +$239K 0.86% 24
2020
Q2 		$1.8M Buy
7,633
+12
+0.2% +$2.74K 0.94% 25
2020
Q1 		$1.54M Sell
7,621
-257
-3% -$56.1K 0.83% 27
2019
Q4 		$1.9M Buy
+7,878
New +$1.74M 0.87% 28

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Mission Creek Capital Partners's AMGN Position: Q1 2026 in Review

Mission Creek Capital Partners increased its Amgen (AMGN) stake by 4.9% in Q1 2026, buying an estimated $210K and bringing the position to 12,744 shares worth $2.8M. The position accounts for 0.56% of the portfolio, ranked #49.

Mission Creek Capital Partners first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $3.08M in Q3 2024. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Mission Creek Capital Partners held 12,744 shares of Amgen worth $2.8M as of Q1 2026.
  • Mission Creek Capital Partners bought 590 Amgen shares in Q1 2026, an estimated $210K.
  • Amgen made up 0.56% of Mission Creek Capital Partners's portfolio in Q1 2026, its #49 holding.
  • Mission Creek Capital Partners first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
  • Mission Creek Capital Partners's Amgen position peaked at $3.08M in Q3 2024.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Mission Creek Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.